Format

Send to

Choose Destination
See comment in PubMed Commons below
Nutrients. 2012 Sep;4(9):1247-59. doi: 10.3390/nu4091247. Epub 2012 Sep 7.

Selenium, selenoprotein genes and Crohn's disease in a case-control population from Auckland, New Zealand.

Author information

  • 1Discipline of Nutrition, FM&HS, University of Auckland, New Zealand. l.gentschew@ikmb.uni-kiel.de

Abstract

New Zealand has one of the highest incidence rates of Crohn's Disease (CD), whilst the serum selenium status of New Zealanders is amongst the lowest in the world. A prospective case-control study in Auckland, New Zealand considered serum selenium as a potential CD risk factor. Serum selenium levels were significantly lower in CD patients compared to controls (101.8 ± 1.02 vs. 111.1 ± 1.01 ng/mL) (p = 5.91 × 10(-8)). Recent detailed studies in the United Kingdom have suggested an optimal serum level around 122 ng/mL, making the average CD patient in New Zealand selenium deficient. Of the 29 single nucleotide polymorphisms (SNPs) tested, 13 were found to significantly interact with serum selenium on CD. After adjustment for multiple testing, a significant interaction with serum selenium on CD was found for three SNPs, namely rs17529609 and rs7901303 in the gene SEPHS1, and rs1553153 in the gene SEPSECS. These three SNPs have not been reported elsewhere as being significantly associated with selenium or CD. It is unclear as to whether lower selenium levels are a cause or an effect of the disease.

KEYWORDS:

Crohn’s Disease; risk factor; selenium; single nucleotide polymorphism

PMID:
23112913
PMCID:
PMC3475235
DOI:
10.3390/nu4091247
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
    Loading ...
    Support Center